Silicon Republic journalist Elaine Burke noticed a significant lack of representation of women at conferences involving AI, data science, and machine learning. To show that Ireland has plenty of female talent in these STEM fields, she compiled a list of 20 women who are doing cutting-edge research. Among the selected women are two of the ADAPT Centre’s researchers: Dr. Rozenn Dahyot, Associate Professor of Statistics at Trinity College Dublin, and Dr. Nicole Baker, Co-Founder of Biologit.
Rozenn Dahyot and Nicole Baker each lead AI research teams, AiMapIT and Biologit within the Adapt Centre.The teams have been funded by the EI commercialisation fund to develop and commercialise their research with the goal of creating a spinout startup company.
Rozenn Dahyot conducts research involving deep learning and computer vision, which lead her to become the principal investigator with the AIMapIT Project at the ADAPT Centre. The AiMapIT team aims to spin-out a computer vision startup that can discover, detect, and map objects by using crowd-sourced data and images from databases such as Google Street View. The goal is to ultimately create a technology that can be used by utility companies and City planners to locate and monitor existing street furniture assets or detect ideal locations for new assists (e.g. 5G base-station locations). The technology also assists in the field of navigation of autonomous vehicles through constantly-changing city landscapes.
Dr. Dahyot is the president of the Irish Pattern Recognition and Classification Society and is heading up the organisation of next year’s European Signal Processing Conference being held in Dublin’s Croke Park.
Nicole Baker co-founded Biologit, a research team within the ADAPT Centre that aims to spin-out an AI startup to simplify pharmacovigilance and clinical safety, ultimately making it more cost-efficient. Dr. Baker comes from pharmaceutical and regulatory, along with clinical research and academic backgrounds.
Biologit has just been awarded the Enterprise Ireland’s Commercialisation Fund which will enable them to develop their first product–Medical Literature Monitoring AI. This software as a service tool allows patients and healthcare workers easy access to accurate safety information about medicinal products.
Share this article: